|
Volumn 12, Issue 4, 1997, Pages 322-328
|
Macrolides are ideal for empiric therapy of community-acquired pneumonia in the immunocompetent host
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN PLUS CLAVULANIC ACID;
AMPICILLIN;
ANTIBIOTIC AGENT;
AZITHROMYCIN;
BETA LACTAM ANTIBIOTIC;
CEFACLOR;
CEFEPIME;
CEFOTAXIME;
CEFOTETAN;
CEFPROZIL;
CEFTAZIDIME;
CEFTRIAXONE;
CEFUROXIME;
CEFUROXIME AXETIL;
CEPHALOSPORIN DERIVATIVE;
CILASTATIN PLUS IMIPENEM;
CLARITHROMYCIN;
DIRITHROMYCIN;
ERYTHROMYCIN;
LORACARBEF;
MACROLIDE;
PENICILLIN G;
PIPERACILLIN PLUS TAZOBACTAM;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
SULTAMICILLIN;
TETRACYCLINE;
TIMENTIN;
ANTIBIOTIC RESISTANCE;
BACTERIAL PNEUMONIA;
BACTERICIDAL ACTIVITY;
COMMUNICABLE DISEASE;
DOSE RESPONSE;
DRUG BIOAVAILABILITY;
DRUG COST;
DRUG HYPERSENSITIVITY;
GASTROINTESTINAL TOXICITY;
HUMAN;
IMMUNOCOMPETENCE;
LIVER TOXICITY;
MINIMUM INHIBITORY CONCENTRATION;
ORAL DRUG ADMINISTRATION;
OTOTOXICITY;
PRIORITY JOURNAL;
REVIEW;
STEVENS JOHNSON SYNDROME;
STREPTOCOCCUS PNEUMONIAE;
ANTI-BACTERIAL AGENTS;
CLINICAL TRIALS;
COMMUNITY-ACQUIRED INFECTIONS;
DRUG RESISTANCE, MICROBIAL;
HUMANS;
IMMUNOCOMPETENCE;
MACROLIDES;
MICROBIAL SENSITIVITY TESTS;
PNEUMONIA, BACTERIAL;
TREATMENT OUTCOME;
|
EID: 0031434828
PISSN: 08820546
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (26)
|
References (34)
|